Profiling and functional annotation of mRNA gene expression in pediatric rhabdomyosarcoma and Ewing's sarcoma

Claudia Baer1, Mattias Nees, Stephen Breit

  • 1Deparment of Pediatric Oncology, Hematology and Immunology, University Children's Hospital, Heidelberg, Germany. claudia.baer@med.uni-heidelberg.de

Insights

This study identifies 101 gene expression markers to distinguish pediatric rhabdomyosarcoma (RMS) from Ewing

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Pediatric small round blue cell tumors (SRBCTs), including rhabdomyosarcoma (RMS) and Ewing's sarcoma (EWS), present diagnostic challenges due to histological similarities.
  • Accurate classification of these tumors is crucial for effective treatment and prognosis.
  • Molecular markers can significantly improve diagnostic accuracy beyond routine histology.

Purpose of the Study:

  • To identify novel gene expression markers that can reliably differentiate between pediatric RMS and EWS.
  • To gain insights into the underlying biology and potential cellular origins of these pediatric cancers through functional gene annotation.

Main Methods:

  • Analysis of mRNA gene expression patterns using Affymetrix oligonucleotide microarrays in 12 primary RMS and 11 EWS samples.
  • Application of three statistical approaches (t-test, SAM, k-nearest neighborhood analysis) to identify significant probe sets.
  • Validation of selected candidate gene expression using quantitative real-time reverse-transcription PCR.
  • Functional annotation of differentially expressed genes to understand biological trends.

Main Results:

  • 101 highly significant probe sets were identified that clearly discriminate between EWS and RMS.
  • Novel marker transcripts, including CITED2, glypican 3 (GPC3), and cyclin D1 (CCND1), were discovered.
  • Genes involved in protein biosynthesis, lipid metabolism, energy generation, and mRNA processing were significantly upregulated in EWS.
  • Functional annotation revealed distinct biological trends and differentiation-specific expression patterns.

Conclusions:

  • Gene expression profiling provides a powerful tool for distinguishing between RMS and EWS.
  • The identified molecular markers and functional insights contribute to a better understanding of SRBCT biology.
  • These findings offer clues regarding the cellular origins of these pediatric tumors and may aid in future classification efforts.